1. A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type KRAS who have received first‐line systemic therapy
   Cathy Eng et al, 2016, International Journal of Cancer CrossRef
2. Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms
   Cheng-Hung Chuang et al, 2016, The Journal of Nutritional Biochemistry CrossRef
3. Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells
   Bo Zhang et al, 2016, Microbial Cell Factories CrossRef
4. Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma
   Vijay Sagar Madamsetty et al, 2019, Bioconjugate Chemistry CrossRef
5. Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors
   Bálint Szokol et al, 2014, ACS Medicinal Chemistry Letters CrossRef
6. Disruption of IGF‑1R signaling by a novel quinazoline derivative, HMJ‑30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U‑2 OS cells
   Yu-Jen Chiu et al, 2018, International Journal of Oncology CrossRef
7. YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study
   Rebecca Senetta et al, 2015, PLOS ONE CrossRef
8. Selective and Nongenetic Peroxidase Tag of Membrane Protein: a Nucleic Acid Tool for Proximity Labeling
   Wen Yang et al, 2022, Analytical Chemistry CrossRef
9. Src is a novel potential off‐target of RXR agonists, 9‐cis‐UAB30 and Targretin, in human breast cancer cells
   Mi‐Sung Kim et al, 2015, Molecular Carcinogenesis CrossRef
10. Colorectal liver metastasis: molecular mechanism and interventional therapy
    Hui Zhou et al, 2022, Signal Transduction and Targeted Therapy CrossRef
11. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
    Chao Wang et al, 2023, International Journal of Biological Macromolecules CrossRef
12. Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
    Lorenza Rimassa et al, 2019, Clinical Colorectal Cancer CrossRef
13. A novel quinazoline derivative, MJ-56, exhibits phototoxicity toward human bladder cancer cells
    Tefu Tsai et al, 2018, Urological Science CrossRef
14. Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
    Shailendra K. Gautam et al, 2020, Cancers CrossRef
15. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
    Ashraf N. Abdalla et al, 2021, Molecules CrossRef
16. The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer
    Seyed Mostafa Parizadeh et al, 2019, IUBMB Life CrossRef
17. Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy
    Lun Tan et al, 2022, Journal of Medicinal Chemistry CrossRef
18. De Novo Proteome Analysis of Genetically Modified Tumor Cells By a Metabolic Labeling/Azide-alkyne Cycloaddition Approach
    Seda Ballikaya et al, 2014, Molecular & Cellular Proteomics CrossRef
19. Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer
    Stacey Shiovitz et al, 2015, Current Gastroenterology Reports CrossRef
20. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer
    Bojiang Chen et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
21. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma
    Özlem Çoban et al, 2019, Drug Development Research CrossRef
22. Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor-stimulated HT29 human colorectal adenocarcinoma cells
    KUANG-CHI LAI et al, 2014, Oncology Reports CrossRef
23. Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
    Sheng Tang et al, 2024, European Journal of Medicinal Chemistry CrossRef